Food and Drug Administration (FDA) has awarded tentative approval for Buspirone HCL Tablets, 15 mg.
With this approval, Teva has tentative approvals for the 3 strengths of Buspirone HCL tablets: 5, 10 and 15 mg.
s anti-infective Ceclor CD; tizanidine HCl tablets, bioequivalent to Elan Pharmaceuticals" spasticity treatment Zanaflex; tramadol HCl tablets, the bioequivalent of Ortho McNeil Pharmaceutical's pain reliever Ultram; and buspirone HCl
tablets, bioequivalent to Bristol-Myers Squibb Co.
Other 2002 introductions included buspirone HCl
tablets, AB rated and bioequivalent to Bristol-Myers Squibb's BuSpar; izanidine HCl tablets, AB rated and bioequivalent to Elan Pharmaceuticals' Zanaflex; and torsemide tablets, AB rated and bioequivalent to Roche Laboratories Inc.
The new generic drugs Mylan Pharmaceuticals has been given FDA approval for include nizatidine capsules, tramadol HCl tablets, lisinopril tablets, lisinopril and hydrochlorothiazide tablets, a variety of levothyroxine sodium tablets, buspirone HCl tablets, ketoprofen capsules, metformin HCl tablets and fluoxetine HCl capsules.
buspirone HCl tablets, giving it four strengths of the antianxiety drug.